Skip to Main Content

Paper Details

Targeting Macrophages with CAR T Cells Delays Solid Tumor Progression and Enhances Antitumor Immunity.
Cancer Immunol Res
26
2022
CAR, CAR T Cells, CAR T-cell, CAR-T, CD8 T, CD8 T cells, F4, F4., F4.CAR, F4.CAR-T, F4.CAR-T cells, IFN, MHC molecules, Macrophages, PD-1, Solid Tumor, T cells, T-cell, TAM, Tumor-associated macrophages, antigenic tumor cell, cancer, cancer cells, chimeric, chimeric antigen receptor (CAR) T cells, macrophage, macrophages, mice, mouse, ovarian and pancreatic cancer, solid tumor, solid tumors, tumor, tumor-infiltrating myeloid cells
Author NameAffiliation
Jalal A KhanPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Jalal A KhanIcahn School of Medicine at Mount Sinai
Miriam MeradPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Miriam MeradThe Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Miriam MeradIcahn School of Medicine at Mount Sinai
Miriam MeradIcahn School of Medicine at Mount Sinai
Miriam MeradPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Miriam MeradThe Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Miriam MeradIcahn School of Medicine at Mount Sinai
Miriam MeradIcahn School of Medicine at Mount Sinai
Brian D BrownPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Brian D BrownIcahn Genomics Institute, Icahn School of Medicine at Mount Sinai
Brian D BrownIcahn School of Medicine at Mount Sinai
Brian D BrownThe Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
  • 1 - 14

Datasets

Release 1.2